Operating Lease, Liability in USD of Lexaria Bioscience Corp. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Lexaria Bioscience Corp. quarterly Operating Lease, Liability history and change rate from Q3 2019 to Q3 2025.
  • Lexaria Bioscience Corp. Operating Lease, Liability for the quarter ending 31 Aug 2025 was $109,319.000, a 20.4% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $109,319 -$28,047 -20.4% 31 Aug 2025 10-K 28 Nov 2025
Q2 2025 $116,586 -$26,001 -18.2% 31 May 2025 10-Q 14 Jul 2025
Q1 2025 $123,723 -$25,162 -16.9% 28 Feb 2025 10-Q 14 Apr 2025
Q3 2024 $137,366 -$26,601 -16.2% 31 Aug 2024 10-K 28 Nov 2025
Q2 2024 $142,587 31 May 2024 10-Q 12 Jul 2024
Q1 2024 $148,885 29 Feb 2024 10-Q 09 Apr 2024
Q3 2023 $163,967 31 Aug 2023 10-Q 12 Jul 2024
Q3 2021 $39,404 +$3,366 +9.3% 31 Aug 2021 10-K 29 Nov 2021
Q2 2021 $98,649 31 May 2021 10-Q 15 Jul 2021
Q1 2021 $107,737 28 Feb 2021 10-Q 14 Apr 2021
Q4 2020 $116,664 30 Nov 2020 10-Q 14 Jan 2021
Q3 2020 $36,038 -$122,735 -77.3% 31 Aug 2020 10-K 29 Nov 2021
Q3 2019 $158,773 01 Sep 2019 10-K 29 Nov 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.